Marı́a Jesús Moro

1.7k total citations
26 papers, 1.1k citations indexed

About

Marı́a Jesús Moro is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Marı́a Jesús Moro has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Marı́a Jesús Moro's work include Multiple Myeloma Research and Treatments (15 papers), Bone health and osteoporosis research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marı́a Jesús Moro is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Bone health and osteoporosis research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marı́a Jesús Moro collaborates with scholars based in Spain and United States. Marı́a Jesús Moro's co-authors include Jesús F. San Miguel, Javier Fernández‐Calvo, Marcos González, Ramón García‐Sánz, Júlia Almeida, Josè Antonio Pérez-Simón, María Dolores Tabernero, Joan Bladé, Miguel Á. Sanz and José‐Ángel Hernández‐Rivas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Marı́a Jesús Moro

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marı́a Jesús Moro Spain	16	761	576	368	266	168	26	1.1k
Thomas Nösslinger Austria	17	1.4k 1.9×	498 0.9×	255 0.7×	684 2.6×	101 0.6×	49	1.6k
A Broustet France	20	1.0k 1.3×	234 0.4×	291 0.8×	353 1.3×	28 0.2×	108	1.5k
H. M. Kvasnicka Germany	19	622 0.8×	442 0.8×	104 0.3×	712 2.7×	77 0.5×	56	995
Kathy L. McGraw United States	18	756 1.0×	558 1.0×	170 0.5×	343 1.3×	28 0.2×	53	1.2k
Maria‐Christina Kyrtsonis Greece	16	445 0.6×	259 0.4×	298 0.8×	252 0.9×	33 0.2×	18	806
James Dalton United States	8	497 0.7×	550 1.0×	210 0.6×	188 0.7×	17 0.1×	14	1.3k
Pilar Hernández-Campo Spain	12	435 0.6×	199 0.3×	127 0.3×	191 0.7×	37 0.2×	16	889
Mitchell A. Bitter United States	14	556 0.7×	301 0.5×	260 0.7×	231 0.9×	19 0.1×	23	1.1k
Sonia Ronconi Italy	17	836 1.1×	574 1.0×	479 1.3×	109 0.4×	59 0.4×	40	1.1k
G.H. Borgström Finland	16	587 0.8×	174 0.3×	173 0.5×	284 1.1×	39 0.2×	24	919

Countries citing papers authored by Marı́a Jesús Moro

Since Specialization

Citations

This map shows the geographic impact of Marı́a Jesús Moro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marı́a Jesús Moro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marı́a Jesús Moro more than expected).

Fields of papers citing papers by Marı́a Jesús Moro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marı́a Jesús Moro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marı́a Jesús Moro. The network helps show where Marı́a Jesús Moro may publish in the future.

Co-authorship network of co-authors of Marı́a Jesús Moro

This figure shows the co-authorship network connecting the top 25 collaborators of Marı́a Jesús Moro. A scholar is included among the top collaborators of Marı́a Jesús Moro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marı́a Jesús Moro. Marı́a Jesús Moro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pino-Montes, J. del, Josep Blanch, Xavier Nogués, et al.. (2016). Expert Consensus on the Management of Patients with Postmenopausal Osteoporosis in the Spanish Healthcare System. Advances in Therapy. 33(4). 658–669. 3 indexed citations

Henríquez, M. Sosa, Pedro Saavedra, Ramón Pérez-Cano, et al.. (2011). Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Aging Clinical and Experimental Research. 23(2). 112–117. 11 indexed citations

Henríquez, M. Sosa, Pedro Saavedra, Esteban Jódar, et al.. (2009). Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study. Aging Clinical and Experimental Research. 21(1). 27–32. 38 indexed citations

Pérez‐Andrés, Martín, Júlia Almeida, M Martín-Ayuso, et al.. (2008). Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease. International Journal of Cancer. 124(2). 367–375. 20 indexed citations

Pérez‐Andrés, Martín, Júlia Almeida, M Martín-Ayuso, et al.. (2006). Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR‐Vβ repertoire. Cancer. 106(6). 1296–1305. 50 indexed citations

Gutiérrez, Norma C., Enrique M. Ocio, Patricia Maiso, et al.. (2005). Gene Expression Profiling of B-Lymphocyte and Plasma Cell Populations from Waldenstrom’s Macroglobulinemia. Comparison with Expression Patterns of the Same Cell-Counterparts from Other B-Cell Neoplasms.. Blood. 106(11). 503–503. 4 indexed citations

Pérez‐Andrés, Martín, Júlia Almeida, M Martín-Ayuso, et al.. (2005). Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Leukemia. 19(3). 449–455. 65 indexed citations

Mateos, María‐Victoria, Ramón García‐Sánz, Ricardo López‐Pérez, et al.. (2002). Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival. British Journal of Haematology. 118(4). 1034–1040. 63 indexed citations

10.

Miguel, Jesús F. San, Júlia Almeida, Gema Mateo, et al.. (2002). Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome. Blood. 99(5). 1853–1856. 99 indexed citations

11.

Mateos, María‐Victoria, Ramón García‐Sánz, Ricardo López‐Pérez, et al.. (2001). p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies. The Hematology Journal. 2(3). 146–149. 23 indexed citations

12.

García‐Sánz, Ramón, Marcos González, María Dolores Tabernero, et al.. (1999). Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics. Blood. 93(3). 1032–1037. 212 indexed citations

13.

Pérez-Simón, Josè Antonio, Ramón García‐Sánz, María Dolores Tabernero, et al.. (1998). Prognostic Value of Numerical Chromosome Aberrations in Multiple Myeloma: A FISH Analysis of 15 Different Chromosomes. Blood. 91(9). 3366–3371. 127 indexed citations

14.

Moro, Marı́a Jesús, Marjolein C. H. van der Meulen, B. Jenny Kiratli, et al.. (1996). Body mass is the primary determinant of midfemoral bone acquisition during adolescent growth. Bone. 19(5). 519–526. 74 indexed citations

15.

Bladé, Joan, Jesús F. San Miguel, M. Fontanillas, et al.. (1996). Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.. Journal of Clinical Oncology. 14(7). 2167–2173. 76 indexed citations

16.

Moro, Marı́a Jesús, Aaron T. Hecker, Mary Bouxsein, & Elizabeth Myers. (1995). Failure load of thoracic vertebrae correlates with lumbar bone mineral density measured by DXA. Calcified Tissue International. 56(3). 206–209. 98 indexed citations

17.

Bladé, Joan, Jesús F. San Miguel, A Alcalá, et al.. (1993). Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.. Journal of Clinical Oncology. 11(6). 1165–1171. 48 indexed citations

18.

Miguel, Jesús F. San, et al.. (1991). Interferon and dexamethasone in multiple myeloma patients refractory to chemotherapy. European Journal of Cancer and Clinical Oncology. 27. S48–S49. 2 indexed citations

19.

Miguel, Jesús F. San, Marı́a Jesús Moro, J Bladé, et al.. (1990). Combination of interferon and dexamethasone in refractory multiple myeloma. Hematological Oncology. 8(4). 185–189. 15 indexed citations

20.

Moro, Marı́a Jesús, et al.. (1980). Ectopic human chorionic gonadotropin: Gynecological tumors and nonmalignant conditions. Gynecologic Oncology. 10(1). 32–38. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact